Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”

Detalles Bibliográficos
Autores principales: Praktiknjo, Michael, Witt, Antonia, Schepis, Filippo, Garcia-Pagan, Juan Carlos, Merli, Manuela, Trebicka, Jonel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411234/
https://www.ncbi.nlm.nih.gov/pubmed/34505036
http://dx.doi.org/10.1016/j.jhepr.2021.100349
_version_ 1783747260120563712
author Praktiknjo, Michael
Witt, Antonia
Schepis, Filippo
Garcia-Pagan, Juan Carlos
Merli, Manuela
Trebicka, Jonel
author_facet Praktiknjo, Michael
Witt, Antonia
Schepis, Filippo
Garcia-Pagan, Juan Carlos
Merli, Manuela
Trebicka, Jonel
author_sort Praktiknjo, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-8411234
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84112342021-09-08 Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites” Praktiknjo, Michael Witt, Antonia Schepis, Filippo Garcia-Pagan, Juan Carlos Merli, Manuela Trebicka, Jonel JHEP Rep Letter to the Editor Elsevier 2021-08-08 /pmc/articles/PMC8411234/ /pubmed/34505036 http://dx.doi.org/10.1016/j.jhepr.2021.100349 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Praktiknjo, Michael
Witt, Antonia
Schepis, Filippo
Garcia-Pagan, Juan Carlos
Merli, Manuela
Trebicka, Jonel
Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
title Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
title_full Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
title_fullStr Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
title_full_unstemmed Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
title_short Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
title_sort reply to: “the clinical advantage of fixed 8-mm diameter vcx stents over underdilated vts stents is not established in refractory ascites”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411234/
https://www.ncbi.nlm.nih.gov/pubmed/34505036
http://dx.doi.org/10.1016/j.jhepr.2021.100349
work_keys_str_mv AT praktiknjomichael replytotheclinicaladvantageoffixed8mmdiametervcxstentsoverunderdilatedvtsstentsisnotestablishedinrefractoryascites
AT wittantonia replytotheclinicaladvantageoffixed8mmdiametervcxstentsoverunderdilatedvtsstentsisnotestablishedinrefractoryascites
AT schepisfilippo replytotheclinicaladvantageoffixed8mmdiametervcxstentsoverunderdilatedvtsstentsisnotestablishedinrefractoryascites
AT garciapaganjuancarlos replytotheclinicaladvantageoffixed8mmdiametervcxstentsoverunderdilatedvtsstentsisnotestablishedinrefractoryascites
AT merlimanuela replytotheclinicaladvantageoffixed8mmdiametervcxstentsoverunderdilatedvtsstentsisnotestablishedinrefractoryascites
AT trebickajonel replytotheclinicaladvantageoffixed8mmdiametervcxstentsoverunderdilatedvtsstentsisnotestablishedinrefractoryascites

Ejemplares similares